WYMM Tour: Oxford

February 20, 2024, 10:00 AM - 5:30 PM
Oxford, United Kingdom

WYMM Tour: Oxford

20 February 2024, 10:00 - 17:40 GMT - Oxford, United Kingdom

Generate ultra-rich data for answers with impact.

Who says you can’t see it all? With a comprehensive view of structural variants and methylation, nanopore technology powers the bigger and bolder research questions you’ve always wanted to ask.​​

Join us on Tuesday 20th February 2024 in Oxford to hear from local experts who are breaking new ground in human genomics, using nanopore technology.​​​

What you're missing matters. Stay on top of what's next.​

Aside from talks ranging from human genomics for rare disease, to sequencing for cancer research, the full-day agenda will include networking breaks, Q&A, product displays, and opportunities to engage with your peers and nanopore experts.

Please note that this is an in-person event.

There is no delegate fee for this event, but registration is required. Lunch and refreshments will be provided. Your place at this event will be confirmed via email from events@nanoporetech.com.

Agenda

Agenda

10:00 – 20:00 hrs GMT

Agenda (subject to change)

10:00 – 11:00 hrs

Registration, breakfast and networking

11:00 – 11:25 hrs

What you're missing matters: Catching the unnoticed

Tonya McSherry, Oxford Nanopore Technologies

11:25 – 12:00 hrs

Translating Oxford Nanopore Technology whole genome sequencing into clinical practice

Richard Scott and Emma McCargow, Genomics England

12:00 – 12:30 hrs

Brain tumour classification with nanopore sequencing

Simon Paine, Nottingham University Hospitals NHS Trust

12:30 – 14:15 hrs

Lunch

14:15 – 14:40 hrs

Oxford Nanopore Technologies bioinformatics update

Philipp Rescheneder, Oxford Nanopore Technologies

14:40 – 15:05 hrs

Integrating short and long read RNA sequencing to study the human heart at single cell resolution

James Cranley, Teichmann Group, Sanger Institute

15:05– 15:30 hrs

Present opportunities and challenges for genome-based diagnostics

Tim Aitman, University of Edinburgh

15:30– 16:30 hrs

Networking session

16:30 – 17:00 hrs

Panel discussion: The future of nanopore sequencing in clinical research

Moderated by Chris Swagell, Oxford Nanopore Technologies

17:00 – 17:30 hrs

Evaluating the diagnostic potential of long reads for rare genetic diseases

Stephan Ossowski, University of Tübingen

17:30 – 17:40 hrs

Closing remarks

Oxford Nanopore Technologies

17:40 – 20:00 hrs

Drinks reception

Speakers

picture of Richard Scott

Richard Scott, CEO, Genomics England

Dr Richard Scott joined the organisation in 2015. He is also a Consultant and Honorary Senior Lectur...

picture of Emma McCargow

Emma McCargow, Programme Lead, Cancer 2.0, Genomics England

...

picture of Simon Paine

Brain tumour classification with nanopore sequencing

Simon Paine, University of Nottingham

Simon is a Consultant Neuropathologist in Nottingham, UK. He is fortunate to work with a range of fa...

picture of Tim Aitman

Present opportunities and challenges for genome-based diagnostics

Tim Aitman, University of Edinburgh

Professor Tim Aitman is Director of the Centre for Genomic and Experimental Medicine and Professor o...

picture of James Cranley

Integrating short and long read RNA sequencing to study the human heart at single cell resolution

James Cranley, Sanger Institute

...

picture of Stephan Ossowski

Evaluating the Diagnostic Potential of Long Reads for Rare Genetic Diseases

Stephan Ossowski, University of Tübingen

Stephan Ossowski is professor for Genome Informatics at the University of Tübingen and vice directo...